Doxycycline hyclate |
Chitosan |
Freeze drying |
Well interconnected pores with diameter about 80–130 µm |
[43] |
Ampicillin and cytochrome C |
Poly(lactic acid) |
Robotic dispensing technique and room temperature ionic liquid |
Pore size of 2.43 µm and microporosity of ~70% |
[45] |
Metoprolol succinate |
Hydroxypropyl-methylcellulose and chitosan |
Gas blowing |
Pore size between 100–1000 µm and porosity of 47.11% ± 1.80% |
[48] |
Amoxicillin trihydrate |
Chitosan |
Freeze drying |
Pore sizes were obtained from100 to 500 µm with increasing the crosslinking agent from 1:0.068 to 1:0.30 (molar ratio-chitosan: crosslinker) |
[44] |
Tetracycline hydrochloride |
Hydroxyapatite/chitosan |
Freeze drying |
Pore diameter 45 ± 17 µm. |
[46] |
Rosiglitazone maleate |
Chitosan/poly(vinyl alcohol) |
Gas foaming |
Superporous hydrogel with capillary porous structures. Porosity increased from 38.3 ± 2.2 to 88.2 ± 2.1 with increasing the amount of glyoxal (crosslinker) |
[49] |
Ranitidine |
Carboxymethylcellulose hydrogel |
Gas foaming |
Porosity decreased from 69.30 ± 4.36 to 42.38 ± 2.68 with the addition of sodium carboxymethyl cellulose |
[50] |
Curcumin |
Nanocellulose reinforced chitosan hydrogel |
Gas foaming |
Highly interconnected pores with pore sizes >100 µm |
[51] |